Palantir (PLTR) 10-Q 9 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 04, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	Palantir Technologies Inc.
Entity Central Index Key	0001321655
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Incorporation, State or Country Code	DE
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	PLTR
Security Exchange Name	NYSE
Entity File Number	001-39540
Entity Address, Address Line One	1555 Blake Street, Suite 250
Entity Address, Postal Zip Code	80202
Entity Tax Identification Number	68-0551851
City Area Code	720
Local Phone Number	358-3679
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,906,589,959
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		97,225,971
Common Class F [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,005,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents		$ 2,335,068	$ 2,011,323
Restricted cash		41,316	37,285
Accounts receivable		174,405	156,932
Marketable securities		148,077
Prepaid expenses and other current assets		112,624	51,889
Total current assets		2,811,490	2,257,429
Property and equipment, net		28,778	29,541
Restricted cash, noncurrent		46,791	79,538
Operating lease right-of-use assets		220,846	217,075
Other assets		116,422	106,921
Total assets		3,224,327	2,690,504
Current liabilities:
Accounts payable		17,654	16,358
Accrued liabilities		179,467	158,546
Deferred revenue	[1]	208,100	189,520
Customer deposits		232,707	210,320
Operating lease liabilities		43,581	29,079
Total current liabilities		681,509	603,823
Deferred revenue, noncurrent	[1]	26,723	50,525
Customer deposits, noncurrent		42,734	81,513
Debt, noncurrent, net			197,977
Operating lease liabilities, noncurrent		219,646	229,800
Other noncurrent liabilities		5,659	4,316
Total liabilities		976,271	1,167,954
Commitments and Contingencies (Note 8)
Stockholders' equity (deficit):
Preferred stock, par value $0.001: 2,000,000 shares authorized and 0 issued and outstanding as of September 30, 2021 and December 31, 2020		0	0
Common stock		1,991	1,792
Additional paid-in capital		7,577,305	6,488,857
Accumulated other comprehensive loss		(1,695)	(2,745)
Accumulated deficit		(5,329,545)	(4,965,354)
Total stockholders' equity		2,248,056	1,522,550
Total liabilities and stockholders' equity		$ 3,224,327	$ 2,690,504
[1]	Deferred revenue as of September 30, 2021 and December 31, 2020 includes $38.6 million and $68.2 million, respectively, from Palantir Technologies Japan, K.K. See Note 6. Equity Method Investments for more information.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000,000	2,000,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	1,991,118,000	1,792,140,000
Common stock, shares outstanding	1,991,118,000	1,792,140,000
Palantir Technologies Japan, K.K. [Member]
Deferred revenue	$ 38.6	$ 68.2
Class A Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,900,441,000	1,542,058,000
Common stock, shares outstanding	1,900,441,000	1,542,058,000
Class B Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	89,672,000	249,077,000
Common stock, shares outstanding	89,672,000	249,077,000
Class F Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenue	$ 392,146	$ 289,366	$ 1,109,022	$ 770,582
Cost of revenue	86,804	149,340	251,841	282,044
Gross profit	305,342	140,026	857,181	488,538
Operating expenses:
Sales and marketing	153,443	334,911	451,919	536,082
Research and development	94,316	313,915	303,311	466,530
General and administrative	149,524	338,977	454,054	503,033
Total operating expenses	397,283	987,803	1,209,284	1,505,645
Loss from operations	(91,941)	(847,777)	(352,103)	(1,017,107)
Interest income	379	494	1,127	4,312
Interest expense	(609)	(2,085)	(3,039)	(12,325)
Change in fair value of warrants		(9,201)		811
Other income (expense), net	(8,528)	(3,293)	(11,297)	1,218
Loss before provision (benefit) for income taxes	(100,699)	(861,862)	(365,312)	(1,023,091)
Provision (benefit) for income taxes	1,438	(8,543)	(1,121)	(5,043)
Net loss	$ (102,137)	$ (853,319)	$ (364,191)	$ (1,018,048)
Net loss per share attributable to common stockholders, basic	$ (0.05)	$ (0.94)	$ (0.19)	$ (1.43)
Net loss per share attributable to common stockholders, diluted	$ (0.05)	$ (0.94)	$ (0.19)	$ (1.43)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic	1,964,395	905,462	1,893,911	713,879
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted	1,964,395	905,462	1,893,911	716,027

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (102,137)	$ (853,319)	$ (364,191)	$ (1,018,048)
Other comprehensive income (loss):
Foreign currency translation adjustments	(1,760)	268	1,050	1,871
Comprehensive loss	$ (103,897)	$ (853,051)	$ (363,141)	$ (1,016,177)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Series H-1 Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]Series H-1 Convertible Preferred Stock [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit	Redeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series K Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series D Convertible Preferred Stock [Member]
Temporary equity, beginning period, Shares at Dec. 31, 2019										4,017,000	742,840,000
Temporary equity, beginning period at Dec. 31, 2019										$ 33,569	$ 2,093,662
Balance at beginning period, Shares at Dec. 31, 2019			581,497,000				6,393,000
Balance at beginning period at Dec. 31, 2019	$ (1,980,642)		$ 588		$ 1,857,331		$ (38,895)	$ (703)	$ (3,798,963)
Conversion of convertible preferred stock to common stock, Shares			793,726,000	28,000							(745,313,000)	(28,000)
Conversion of convertible preferred stock to common stock	2,105,319	$ 100	$ 794		2,104,525	$ 100					$ (2,105,319)	$ (100)
Issuance of preferred stock upon net exercise of preferred stock warrants, Shares													121,000	2,380,000
Issuance of preferred stock upon net exercise of preferred stock warrants													$ 947	$ 10,810
Repurchase of common stock, held in treasury, Shares			(808,000)				808,000
Repurchase of common stock, held in treasury	(3,777)						$ (3,777)
Retirement of treasury stock, Shares							(7,201,000)
Retirement of treasury stock			$ (7)		(42,665)		$ 42,672
Issuance of common stock upon net exercise of common stock warrants and other, Shares			7,631,000
Issuance of common stock upon net exercise of common stock warrants and other			$ 8		(8)
Issuance of common stock upon net exercise of common stock warrants, Shares			206,501,000
Issuance of common stock upon net exercise of common stock warrants	$ 942,529		$ 207		942,322
Conversion of redeemable convertible preferred stock to common stock, Shares	(4,017,000)		4,017,000
Conversion of redeemable convertible preferred stock to common stock	$ 33,569		$ 4		33,565					$ (33,569)
Conversion of preferred stock warrants to common stock warrants	31,007				31,007
Issuance of common stock from the exercise of stock options	116,030		$ 69		115,961
Issuance of common stock from the exercise of stock options, Shares			69,444,000
Issuance of common stock upon vesting of RSUs, Shares			68,150,000
Issuance of common stock upon vesting of RSUs			$ 68		(68)
Stock-based compensation	1,024,000				1,024,000
Settlement of employee loan accounted for as a modification to stock option (Shares)			(3,500,000)
Settlement of employee loan accounted for as a modification to stock option (Value)	(205)		$ (4)		(201)
Other comprehensive income (loss)	1,871							1,871
Net loss	(1,018,048)								(1,018,048)
Balance at end of period, Shares at Sep. 30, 2020			1,726,686,000
Balance at end of period at Sep. 30, 2020	1,251,753		$ 1,727		6,065,869			1,168	(4,817,011)
Temporary equity, beginning period, Shares at Jun. 30, 2020										4,017,000	742,933,000
Temporary equity, beginning period at Jun. 30, 2020										$ 33,569	$ 2,094,509
Balance at beginning period, Shares at Jun. 30, 2020			736,635,000
Balance at beginning period at Jun. 30, 2020	(1,398,701)		$ 737		2,563,354			900	(3,963,692)
Conversion of convertible preferred stock to common stock, Shares			793,726,000								(745,313,000)
Conversion of convertible preferred stock to common stock	2,105,319		$ 794		2,104,525						$ (2,105,319)
Issuance of preferred stock upon net exercise of preferred stock warrants, Shares														2,380,000
Issuance of preferred stock upon net exercise of preferred stock warrants														$ 10,810
Issuance of common stock upon net exercise of common stock warrants and other, Shares			7,631,000
Issuance of common stock upon net exercise of common stock warrants and other			$ 8		(8)
Issuance of common stock upon net exercise of common stock warrants, Shares			88,280,000
Issuance of common stock upon net exercise of common stock warrants	404,679		$ 88		404,591
Conversion of redeemable convertible preferred stock to common stock, Shares			4,017,000							(4,017,000)
Conversion of redeemable convertible preferred stock to common stock	33,569		$ 4		33,565					$ (33,569)
Conversion of preferred stock warrants to common stock warrants	31,007				31,007
Issuance of common stock from the exercise of stock options	87,207		$ 32		87,175
Issuance of common stock from the exercise of stock options, Shares			31,748,000
Issuance of common stock upon vesting of RSUs, Shares			68,149,000
Issuance of common stock upon vesting of RSUs			$ 68		(68)
Stock-based compensation	841,929				841,929
Settlement of employee loan accounted for as a modification to stock option (Shares)			(3,500,000)
Settlement of employee loan accounted for as a modification to stock option (Value)	(205)		$ (4)		(201)
Other comprehensive income (loss)	268							268
Net loss	(853,319)								(853,319)
Balance at end of period, Shares at Sep. 30, 2020			1,726,686,000
Balance at end of period at Sep. 30, 2020	1,251,753		$ 1,727		6,065,869			1,168	(4,817,011)
Balance at beginning period, Shares at Dec. 31, 2020			1,792,140,000
Balance at beginning period at Dec. 31, 2020	1,522,550		$ 1,792		6,488,857			(2,745)	(4,965,354)
Issuance of common stock upon net exercise of common stock warrants and other, Shares			4,664,000
Issuance of common stock upon net exercise of common stock warrants and other	1,712		$ 6		1,706
Issuance of common stock from the exercise of stock options	$ 474,683		$ 155		474,528
Issuance of common stock from the exercise of stock options, Shares	155,720,000		155,720,000
Issuance of common stock upon vesting of RSUs, Shares			37,123,000
Issuance of common stock upon vesting of RSUs			$ 37		(37)
Issuance of common stock upon vesting of growth units, Shares			1,471,000
Issuance of common stock upon vesting of growth units			$ 1		(1)
Stock-based compensation	$ 612,252				612,252
Other comprehensive income (loss)	1,050							1,050
Net loss	(364,191)								(364,191)
Balance at end of period, Shares at Sep. 30, 2021			1,991,118,000
Balance at end of period at Sep. 30, 2021	2,248,056		$ 1,991		7,577,305			(1,695)	(5,329,545)
Balance at beginning period, Shares at Jun. 30, 2021			1,936,578,000
Balance at beginning period at Jun. 30, 2021	2,068,963		$ 1,937		7,294,369			65	(5,227,408)
Issuance of common stock from the exercise of stock options	97,995		$ 41		97,954
Issuance of common stock from the exercise of stock options, Shares			41,249,000
Issuance of common stock upon vesting of RSUs, Shares			13,291,000
Issuance of common stock upon vesting of RSUs			$ 13		(13)
Stock-based compensation	184,995				184,995
Other comprehensive income (loss)	(1,760)							(1,760)
Net loss	(102,137)								(102,137)
Balance at end of period, Shares at Sep. 30, 2021			1,991,118,000
Balance at end of period at Sep. 30, 2021	$ 2,248,056		$ 1,991		$ 7,577,305			$ (1,695)	$ (5,329,545)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net loss	$ (364,191)	$ (1,018,048)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	11,057	10,308
Stock-based compensation	611,308	1,028,914
Non-cash operating lease expense	23,417	28,815
Unrealized loss from marketable securities	7,238	0
Other operating activities	3,076	3,621
Changes in operating assets and liabilities:
Accounts receivable	(15,412)	(112,723)
Prepaid expenses and other current assets	(7,872)	(11,598)
Other assets	(8,155)	(20,944)
Accounts payable	1,158	(29,372)
Accrued liabilities	20,360	42,138
Deferred revenue, current and noncurrent	(3,781)	(30,937)
Customer deposits, current and noncurrent	(16,227)	(140,162)
Operating lease liabilities, current and noncurrent	(22,786)	(34,725)
Other noncurrent liabilities	1,234	6,393
Net cash used in operating activities	240,424	(278,320)
Investing activities
Purchases of property and equipment	(6,783)	(7,475)
Purchases of marketable securities	(155,315)	0
Purchases of alternative investments	(50,941)	0
Other investing activities	(3,000)	(2,500)
Net cash used in investing activities	(216,039)	(9,975)
Financing activities
Proceeds from the issuance of common stock, net of issuance costs	0	942,529
Proceeds from issuance of debt, net of issuance costs	0	199,369
Principal payments on borrowings	(200,000)	(400,000)
Proceeds from the exercise of common stock options	474,683	79,473
Repurchase of common stock	0	(3,777)
Other financing activities	(401)	(250)
Net cash provided by (used in) financing activities	274,282	817,344
Effect of foreign exchange on cash, cash equivalents, and restricted cash	(3,638)	(678)
Net increase in cash, cash equivalents, and restricted cash	295,029	528,371
Cash, cash equivalents, and restricted cash - beginning of period	2,128,146	1,401,962
Cash, cash equivalents, and restricted cash - end of period	2,423,175	1,930,333
Supplemental disclosures of cash flow information:
Cash paid for income taxes	3,588	9,143
Cash paid for interest	2,774	9,737
Supplemental disclosures of non-cash investing and financing information:
Receivable from the exercise of common stock options included in prepaid expenses and other current assets	396	36,557
Cashless net exercise of warrants for convertible preferred stock	0	10,810
Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock	0	2,138,988
Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock	$ 0	$ 31,007

Organization

Organization	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts ; ; ; ; Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2. Significant Accounting Policies 10-K Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2021 2020 Cash and cash equivalents $ 2,335,068 $ 1,800,190 Restricted cash 41,316 43,800 Restricted cash, noncurrent 46,791 86,343 Total cash, cash equivalents, and restricted cash $ 2,423,175 $ 1,930,333 Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized COVID-19 written-off Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), 2019-12 2019-12 2019-12

Contract Liabilities and Remain

Contract Liabilities and Remaining Performance Obligations	9 Months Ended
	Sep. 30, 2021
Revenue from Contract with Customer [Abstract]
Contract Liabilities and Remaining Performance Obligations	3. Contract Liabilities and Remaining Performance Obligations Contract Liabilities The Company’s contract liabilities consist of deferred revenue and customer deposits. As of September 30, 2021 and December 31, 2020, the Company’s contract liability balances were $510.3 million and $531.9 million, respectively. Revenue of $347.7 million and $406.4 million was recognized during the nine months ended September 30, 2021 and 2020, respectively, that was included in the contract liability balances as of December 31, 2020 and 2019, respectively. Remaining Performance Obligations The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. The Company’s remaining performance obligations were $873.9 million as of September 30, 2021, of which the Company expects to recognize approximately 45% as revenue over the next twelve months. Disaggregation of Revenue See Note 13. Segment and Geographic Information

Investments and Fair Value Meas

Investments and Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Investments and Fair Value Measurements	4. Investments and Fair Value Measurements Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, equity securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of September 30, 2021 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 767,372 $ 767,372 $ — $ — Certificates of deposit 60,061 — 60,061 — Marketable securities 148,077 148,077 — — Total $ 975,510 $ 915,449 $ 60,061 $ — As of December 31, 2020 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 1,075,783 $ 1,075,783 $ — $ — Certificates of deposit 74,097 — 74,097 — Total $ 1,149,880 $ 1,075,783 $ 74,097 $ — Certificates of Deposit The Company’s Level 2 instruments consist of cash equivalents and restricted cash invested in certificates of deposit. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses on certificate of deposits as of September 30, 2021 and December 31, 2020 were not material. Marketable Securities Marketable securities consist of equity securities in publicly-traded companies and are recorded at fair market value each reporting period. Realized and unrealized gains and losses are recorded in other income (expense), net on the condensed consolidated statements of operations. During the three and nine months ended September 30, 2021, the Company recorded net unrealized losses of Investments The Company approved and entered into certain agreements (“Investment Agreements”) to purchase, or commit to purchase, as further discussed in Note 8. Commitments and Contingencies—Investment Commitments, million of contractual options. The terms of such contracts, including such contractual options, range three During 2021, the Company assessed the concurrent agreements under the non-monetary Revenue from Contracts with Customers The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands): Entity (1) Share Amount Investment Amount Celularity 2,000 $ 20,000 Faraday Future 2,500 25,000 Astrocast 1,520 5,000 BlackSky 800 8,000 Lilium 4,100 41,000 Roivant Sciences 3,000 30,000 Sarcos Robotics 2,100 21,000 Autonomous aerial vehicle company (2) 3,000 3,000 Total 19,020 $ 153,000 (1) Investments are in publicly-traded marketable securities, unless otherwise noted. (2) Investment in privately-held company. Privately-Held Securities Equity investments in private-held companies without readily determinable fair values are recorded using the measurement alternative of cost less impairment, if any, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. As of September 30, 2021, the carrying value of investments without readily determinable fair values were recorded in other assets in the Company’s condensed consolidated balance sheets and were not material. Alternative Investments The Company purchased $50.9 million in 100-ounce

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	5. Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of September 30, As of December 31, Leasehold improvements $ 80,215 $ 85,196 Computer equipment, software, and other 25,451 22,275 Furniture and fixtures 10,021 9,976 Construction in progress 5,305 493 Total property and equipment, gross 120,992 117,940 Less: accumulated depreciation and amortization (92,214) (88,399) Total property and equipment, net $ 28,778 $ 29,541 Depreciation and amortization expense related to property and equipment, net was $3.1 million and $2.5 million for the three months ended September 30, 2021 and 2020, respectively, and $9.3 million and $9.3 million for the nine months ended September 30, 2021 and 2020, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of September 30, As of December 31, Accrued payroll and related expenses $ 100,157 $ 85,466 Accrued other liabilities 79,310 73,080 Total accrued liabilities $ 179,467 $ 158,546

Equity Method Investments

Equity Method Investments	9 Months Ended
	Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	6. Equity Method Investments Palantir Technologies Japan, K.K. During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”), to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee.

Debt

Debt	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
Debt	7. Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility which has been subsequently amended (the “2014 Credit Facility”). The 2014 Credit Facility incurred interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. Interest and commitment fees are payable at the end of an interest period or at each three-month interval if the interest period is longer than three months. The 2014 Credit Facility, as amended, matures on June 4, 2023. During April 2021, the Company entered into an amendment to the 2014 Credit Facility, which provided for an increase of $200.0 million to the revolving commitments of the existing lenders under the 2014 Credit Facility, for total revolving commitments of $400.0 million, and which also provided for an incremental loan facility for additional loans in an aggregate principal amount of up to $100.0 million with one or more existing or new lenders upon mutual agreement between the Company and such lenders. Upon entering into the amendment, the Company repaid its outstanding term loans of $200.0 million. As of September 30, 2021, the Company had no amounts outstanding under the 2014 Credit Facility and a $400.0 million undrawn revolving credit facility. The 2014 Credit Facility contains customary r epresentat

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Purchase Commitments In December 2019, the Company entered into, and subsequently amended during December 2020, a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional carryover period through June 30, 2029, in exchange for various discounts on such services. I f the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract. commitment for the contract year ending June 30, 2022. In June 2020, the Company entered into an additional commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of September 30, 2021, the Company had satisfied $8.0 million of its commitment. Investment Commitments The Company approved and entered into certain Investment Agreements with Investees, as further discussed in Note 4. Investments and Fair Value Measurements - Investments . The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands): Entity Investment Committed Committed Mobility company (1) May 11, 2021 2,000 $ 20,000 Wejo May 28, 2021 3,500 35,000 Babylon Health (1) (2) June 3, 2021 3,500 35,000 Boxed ( 2 June 13, 2021 2,000 20,000 Pear Therapeutics June 21, 2021 1,000 10,000 Autonomous vehicle company ( 2 June 22, 2021 1,800 18,000 Fast Radius ( 2 July 18, 2021 2,000 20,000 Tritium ( 2 July 27, 2021 1,500 15,000 AdTheorent ( 2 July 27, 2021 1,500 15,000 FinAccel August 2, 2021 1,000 10,000 Energy Vault ( 2 September 8, 2021 850 8,500 Electric vehicle charging company ( 2 September 10, 2021 2,000 20,000 Total 22,650 $ 226,500 (1) The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events (2) Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed. Litigation and Legal Proceedings From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company is unable to predict whether or when any such matters may arise, the outcome of these matters, or the ultimate legal and financial liability, and cannot reasonably estimate the possible loss or range of loss at this time and accordingly has not accrued a related liability. On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”), filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs. The Company believes this lawsuit is without merit and is vigorously defending itself against it. Given the uncertainty of litigation, it may be reasonably possible that the Company will incur a loss with regards to the matter; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable, at this time, to estimate the overall effects that may result from the lawsuit on its financial condition, results of operations, or cash flows. As of September 30, 2021, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that were expected to have a material adverse impact on its condensed consolidated financial statements. Letters of Credit and Guarantees The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $88.1 million and $116.8 million as of September 30, 2021 and December 31, 2020, respectively, all of which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As of September 30, 2021, these letters of credit and guarantees had expiration dates through August 2028. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of September 30, 2021 and December 31, 2020. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of September 30, 2021 and December 31, 2020. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure	9. Stockholders’ Equity The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described below and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100 million of the Company’s equity securities as of September 30, 2021. Holders of common stock are entitled to dividends when, as and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of September 30, 2021. In connection with the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“Direct Listing”) in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock. The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of September 30, 2021 As of December 31, 2020 Authorized Issued and Authorized Issued and Common stock: Class A 20,000,000 1,900,441 20,000,000 1,542,058 Class B 2,700,000 89,672 2,700,000 249,077 Class F 1,005 1,005 1,005 1,005 Total 22,701,005 1,991,118 22,701,005 1,792,140

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation Stock Options The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): Options Outstanding Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Life (years) Aggregate Intrinsic Value Balance as of December 31, 2020 535,767 $ 6.12 7.99 $ 9,340,245 Options exercised (155,720 ) 3.05 Options canceled and forfeited (5,518 ) 5.26 Balance as of September 30, 2021 374,529 $ 7.40 8.82 $ 6,230,308 Options vested and exercisable as of September 30, 2021 182,617 $ 4.48 7.08 $ 3,571,719 As of September 30, 2021, the unrecognized expense related to options outstanding was $940.0 million, which is expected to be recognized over a weighted-average service period of eight years. RSUs The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): RSUs Weighted Average Unvested and outstanding as of December 31, 2020 184,870 $ 6.97 RSUs granted 25,093 24.01 RSUs vested (37,123 ) 8.17 RSUs canceled (6,807 ) 8.18 Unvested and outstanding as of September 30, 2021 166,033 $ 9.22 As of September 30, 2021, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $985.1 million, which the Growth Units In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition, which was satisfied in March 2021. In March 2021, the 3.6 million outstanding growth units vested and, per the formula applicable to the awards, converted into 1.5 million shares of common stock. During the three months ended March 31, 2021, the Company recognized the remaining stock-based compensation expense related to the growth units of $1.2 million. Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Cost of revenue $ 14,860 $ 94,385 $ 54,866 $ 120,285 Sales and marketing 57,124 263,958 186,418 322,353 Research and development 34,472 256,769 122,976 309,698 General and administrative 78,379 231,847 247,048 276,578 Total stock-based compensation expense (1) $ 184,835 $ 846,959 $ 611,308 $ 1,028,914 (1) On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes The Company recorded a provision for income taxes of $1.4 million and a benefit from a from non-deductible The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis, and it establishes a valuation allowance if it is more-likely-than-not

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	12. Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Numerator Net loss attributable to common stockholders $ (102,137 ) $ (853,319 ) $ (364,191 ) $ (1,018,048 ) Less: Change in fair value attributable to participating securities — — — (5,483 ) Net loss attributable to common stockholders, for diluted net loss per share $ (102,137 ) $ (853,319 ) $ (364,191 ) $ (1,023,531 ) Denominator Weighted-average shares used in computing net loss per share, basic 1,964,395 905,462 1,893,911 713,879 Weighted-average shares used in computing net loss per share, diluted 1,964,395 905,462 1,893,911 716,027 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.05 ) $ (0.94 ) $ (0.19 ) $ (1.43 ) Net loss per share attributable to common stockholders, diluted $ (0.05 ) $ (0.94 ) $ (0.19 ) $ (1.43 ) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of September 30, 2021 2020 Warrants to purchase common stock 13,042 19,068 Options and Stock Appreciation Rights issued and outstanding 374,555 587,977 RSUs outstanding 166,033 199,655 Growth units outstanding — 3,583 Total 553,630 810,283

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Segment and Geographic Information	13. Segment and Geographic Information The following tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue: Government $ 217,836 $ 162,561 $ 658,375 $ 420,257 Commercial 174,310 126,805 450,647 350,325 Total revenue $ 392,146 $ 289,366 $ 1,109,022 $ 770,582 Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Contribution: Government $ 125,706 $ 93,962 $ 400,705 $ 226,186 Commercial 98,177 69,496 245,841 168,908 Total contribution $ 223,883 $ 163,458 $ 646,546 $ 395,094 The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Loss from operations $ (91,941) $ (847,777) $ (352,103) $ (1,017,107) Research and development expenses (1) 59,844 57,146 180,335 156,832 General and administrative expenses (1) 71,145 107,130 207,006 226,455 Stock-based compensation expense 184,835 846,959 611,308 1,028,914 Total contribution $ 223,883 $ 163,458 $ 646,546 $ 395,094 (1) Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended September 30, 2021 2020 Amount % Amount % Revenue: United States $ 227,285 58 % $ 156,336 54 % United Kingdom 47,914 12 % 35,432 12 % Rest of world (1) 116,947 30 % 97,598 34 % Total revenue $ 392,146 100 % $ 289,366 100 % (1) (1)

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events Investment Commitments and Investments The Company approved and entered into additional Investment Agreements from October 1, 2021 through the date of this filing. As of the date of this filing, the Company had additional outstanding investment commitments, subject to applicable terms and conditions, to purchase a total of 2.6 million shares for an aggregate purchase price of $26.0 million. The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands): Entity Investment Agreement Committed Committed Telecommunications company (1) October 6, 2021 1,600 $ 16,000 Rigetti & Co, Inc. (1) October 6, 2021 1,000 10,000 Tota l 2,600 $ 26,000 (1) In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from three Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands): Entity Share Amount Investment Amount Babylon Health (1) 3,500 $ 35,000 Mobility company (1) 2,000 20,000 Total 5,500 $ 55,000 (1) Note 8. Commitments and Contingencies - Investment Commitments

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. The Company’s fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2020, included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. The Company ceased to be an emerging growth company as of December 31, 2020, which accelerated its adoption of Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842) These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes included in its Annual Report on Form 10-K
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts ; ; ; ;
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2021 2020 Cash and cash equivalents $ 2,335,068 $ 1,800,190 Restricted cash 41,316 43,800 Restricted cash, noncurrent 46,791 86,343 Total cash, cash equivalents, and restricted cash $ 2,423,175 $ 1,930,333
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses, if any. The Company generally grants non-collateralized COVID-19 written-off
Concentrations of Credit Risk and Other Concentrations	Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents primarily consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balances as of September 30, 2021 and December 31, 2020 were $174.4 million and $156.9 million, respectively. Customer H represented 11% of total accounts receivable as of September 30, 2021. Customer G represented 13% of total accounts receivable as of December 31, 2020. No other customer represented more than 10% of total accounts receivable as of September 30, 2021 and December 31, 2020. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2021 and December 31, 2020, the Company had not experienced any significant losses on its accounts receivable. For the three and nine months ended September 30, 2021, no customer represented more than 10% of total revenue. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F, which is in the government operating segment, represented 11% of total revenue. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740), 2019-12 2019-12 2019-12

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2021 2020 Cash and cash equivalents $ 2,335,068 $ 1,800,190 Restricted cash 41,316 43,800 Restricted cash, noncurrent 46,791 86,343 Total cash, cash equivalents, and restricted cash $ 2,423,175 $ 1,930,333

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis	The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of September 30, 2021 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 767,372 $ 767,372 $ — $ — Certificates of deposit 60,061 — 60,061 — Marketable securities 148,077 148,077 — — Total $ 975,510 $ 915,449 $ 60,061 $ — As of December 31, 2020 Total Level 1 Level 2 Level 3 Assets: Money market funds $ 1,075,783 $ 1,075,783 $ — $ — Certificates of deposit 74,097 — 74,097 — Total $ 1,149,880 $ 1,075,783 $ 74,097 $ —
Summary of Investments Under Investment Agreements	The following table presents the details of the investments purchased under such Investment Agreements during the nine months ended September 30, 2021 (in thousands): Entity (1) Share Amount Investment Amount Celularity 2,000 $ 20,000 Faraday Future 2,500 25,000 Astrocast 1,520 5,000 BlackSky 800 8,000 Lilium 4,100 41,000 Roivant Sciences 3,000 30,000 Sarcos Robotics 2,100 21,000 Autonomous aerial vehicle company (2) 3,000 3,000 Total 19,020 $ 153,000 (1) Investments are in publicly-traded marketable securities, unless otherwise noted. (2) Investment in privately-held company.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2021
Balance Sheet Related Disclosures [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of September 30, As of December 31, Leasehold improvements $ 80,215 $ 85,196 Computer equipment, software, and other 25,451 22,275 Furniture and fixtures 10,021 9,976 Construction in progress 5,305 493 Total property and equipment, gross 120,992 117,940 Less: accumulated depreciation and amortization (92,214) (88,399) Total property and equipment, net $ 28,778 $ 29,541
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of September 30, As of December 31, Accrued payroll and related expenses $ 100,157 $ 85,466 Accrued other liabilities 79,310 73,080 Total accrued liabilities $ 179,467 $ 158,546

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2021
Investment Commitments [Abstract]
Summary of Investment commitments	The following table presents details related to the Company’s investment commitments outstanding as of September 30, 2021 (in thousands): Entity Investment Committed Committed Mobility company (1) May 11, 2021 2,000 $ 20,000 Wejo May 28, 2021 3,500 35,000 Babylon Health (1) (2) June 3, 2021 3,500 35,000 Boxed ( 2 June 13, 2021 2,000 20,000 Pear Therapeutics June 21, 2021 1,000 10,000 Autonomous vehicle company ( 2 June 22, 2021 1,800 18,000 Fast Radius ( 2 July 18, 2021 2,000 20,000 Tritium ( 2 July 27, 2021 1,500 15,000 AdTheorent ( 2 July 27, 2021 1,500 15,000 FinAccel August 2, 2021 1,000 10,000 Energy Vault ( 2 September 8, 2021 850 8,500 Electric vehicle charging company ( 2 September 10, 2021 2,000 20,000 Total 22,650 $ 226,500 (1) The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events (2) Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Summary of Total Authorized, Issued, And Outstanding Shares	The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of September 30, 2021 As of December 31, 2020 Authorized Issued and Authorized Issued and Common stock: Class A 20,000,000 1,900,441 20,000,000 1,542,058 Class B 2,700,000 89,672 2,700,000 249,077 Class F 1,005 1,005 1,005 1,005 Total 22,701,005 1,991,118 22,701,005 1,792,140

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2021
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): Options Outstanding Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Life (years) Aggregate Intrinsic Value Balance as of December 31, 2020 535,767 $ 6.12 7.99 $ 9,340,245 Options exercised (155,720 ) 3.05 Options canceled and forfeited (5,518 ) 5.26 Balance as of September 30, 2021 374,529 $ 7.40 8.82 $ 6,230,308 Options vested and exercisable as of September 30, 2021 182,617 $ 4.48 7.08 $ 3,571,719
Summary of RSU Activity	The following table summarizes the RSU activity for the nine months ended September 30, 2021 (in thousands, except per share amounts): RSUs Weighted Average Unvested and outstanding as of December 31, 2020 184,870 $ 6.97 RSUs granted 25,093 24.01 RSUs vested (37,123 ) 8.17 RSUs canceled (6,807 ) 8.18 Unvested and outstanding as of September 30, 2021 166,033 $ 9.22
Summary of Stock-Based Compensation Expense	Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Cost of revenue $ 14,860 $ 94,385 $ 54,866 $ 120,285 Sales and marketing 57,124 263,958 186,418 322,353 Research and development 34,472 256,769 122,976 309,698 General and administrative 78,379 231,847 247,048 276,578 Total stock-based compensation expense (1) $ 184,835 $ 846,959 $ 611,308 $ 1,028,914 (1) On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Numerator Net loss attributable to common stockholders $ (102,137 ) $ (853,319 ) $ (364,191 ) $ (1,018,048 ) Less: Change in fair value attributable to participating securities — — — (5,483 ) Net loss attributable to common stockholders, for diluted net loss per share $ (102,137 ) $ (853,319 ) $ (364,191 ) $ (1,023,531 ) Denominator Weighted-average shares used in computing net loss per share, basic 1,964,395 905,462 1,893,911 713,879 Weighted-average shares used in computing net loss per share, diluted 1,964,395 905,462 1,893,911 716,027 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.05 ) $ (0.94 ) $ (0.19 ) $ (1.43 ) Net loss per share attributable to common stockholders, diluted $ (0.05 ) $ (0.94 ) $ (0.19 ) $ (1.43 )
Summary of Antidilutive Securities	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of September 30, 2021 2020 Warrants to purchase common stock 13,042 19,068 Options and Stock Appreciation Rights issued and outstanding 374,555 587,977 RSUs outstanding 166,033 199,655 Growth units outstanding — 3,583 Total 553,630 810,283

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2021
Segment Reporting [Abstract]
Summary of Financial Information for Each Reportable Segment	Financial information for each reportable segment was as Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue: Government $ 217,836 $ 162,561 $ 658,375 $ 420,257 Commercial 174,310 126,805 450,647 350,325 Total revenue $ 392,146 $ 289,366 $ 1,109,022 $ 770,582 Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Contribution: Government $ 125,706 $ 93,962 $ 400,705 $ 226,186 Commercial 98,177 69,496 245,841 168,908 Total contribution $ 223,883 $ 163,458 $ 646,546 $ 395,094
Summary of Reconciliation of Segment Financial Information to Loss from Operations	The reconciliation of contribution to loss from operations is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Loss from operations $ (91,941) $ (847,777) $ (352,103) $ (1,017,107) Research and development expenses (1) 59,844 57,146 180,335 156,832 General and administrative expenses (1) 71,145 107,130 207,006 226,455 Stock-based compensation expense 184,835 846,959 611,308 1,028,914 Total contribution $ 223,883 $ 163,458 $ 646,546 $ 395,094 (1)
Summary of Revenue by Geography	Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended September 30, 2021 2020 Amount % Amount % Revenue: United States $ 227,285 58 % $ 156,336 54 % United Kingdom 47,914 12 % 35,432 12 % Rest of world (1) 116,947 30 % 97,598 34 % Total revenue $ 392,146 100 % $ 289,366 100 % (1) Nine Months Ended September 30, 2021 2020 Amount % Amount % Revenue: United States $ 625,662 56 % $ 391,106 51 % United Kingdom 122,234 11 % 94,440 12 % France 61,558 6 % 78,572 10 % Rest of world (1) 299,568 27 % 206,464 27 % Total revenue $ 1,109,022 100 % $ 770,582 100 % (1)

Subsequent Events (Tables)

Subsequent Events (Tables)	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Summary of Additional Investment Commitments	The following table presents details regarding the Company’s additional investment commitments outstanding as of the date of this filing (in thousands): Entity Investment Agreement Committed Committed Telecommunications company (1) October 6, 2021 1,600 $ 16,000 Rigetti & Co, Inc. (1) October 6, 2021 1,000 10,000 Tota l 2,600 $ 26,000 (1)
Summary of Investment Commitments	In connection with signing each of the Investment Agreements entered into between October 1, 2021 and the date of this filing, each Investee or an associated entity and the Company entered into a commercial contract for the Company’s products and services. The maximum potential revenue from these commercial contracts, including option years, is $26.0 million, and the terms of such agreements range from three Additionally, from October 1 to the date of this filing, the Company purchased 5.5 million shares for an aggregate purchase price of $55.0 million, as set forth in the following table (in thousands): Entity Share Amount Investment Amount Babylon Health (1) 3,500 $ 35,000 Mobility company (1) 2,000 20,000 Total 5,500 $ 55,000 (1) Note 8. Commitments and Contingencies - Investment Commitments

Significant Accounting Polici_4

Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 2,335,068	$ 2,011,323	$ 1,800,190
Restricted cash	41,316	37,285	43,800
Restricted cash, noncurrent	46,791	79,538	86,343
Total cash, cash equivalents, and restricted cash	$ 2,423,175	$ 2,128,146	$ 1,930,333	$ 1,401,962

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Accounts receivable	$ 174,405,000		$ 174,405,000		$ 156,932,000
Allowance for doubtful accounts on trade receivables	$ 0		$ 0		$ 0
Accounts Receivable [Member] | Customer H [Member]
Percentage Concentration			11.00%
Accounts Receivable [Member] | Customer G [Member]
Percentage Concentration					13.00%
Revenue Benchmark [Member] | Customer A [Member]
Percentage Concentration		10.00%
Revenue Benchmark [Member] | Customer F [Member]
Percentage Concentration				11.00%
Minimum [Member]
Equity method investment ownership percentage	20.00%		20.00%
Minimum [Member] | Revenue Benchmark [Member]
Percentage Concentration	10.00%	10.00%	10.00%	10.00%
Maximum [Member] | Accounts Receivable [Member]
Percentage Concentration			10.00%		10.00%
Maximum [Member] | Revenue Benchmark [Member]
Percentage Concentration	10.00%	10.00%	10.00%	10.00%

Contract Liabilities and Rema_2

Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Performance obligation	$ 873.9
Performance obligation percentage to be recognised as revenue in the next twelve months	45.00%
Contract with customer, liability	$ 510.3		$ 531.9
Revenue recognized from contract liability balances	$ 347.7	$ 406.4

Investments and Fair Value Me_3

Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 767,372	$ 1,075,783
Certificates of deposit	60,061	74,097
Marketable Securities	148,077
Total	975,510	1,149,880
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	767,372	1,075,783
Marketable Securities	148,077
Total	915,449	1,075,783
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	60,061	74,097
Total	$ 60,061	$ 74,097

Investments and Fair Value Me_4

Investments and Fair Value Measurements - Summary Of The Investments Purchased Under Such Investment Agreements (Detail) $ in Thousands	Sep. 30, 2021USD ($)shares	[1]
Investment Amount | $	$ 153,000
Investment Owned, Balance, Shares | shares	19,020
Celularity [Member]
Investment Amount | $	$ 20,000
Investment Owned, Balance, Shares | shares	2,000
Faraday Future [Member]
Investment Amount | $	$ 25,000
Investment Owned, Balance, Shares | shares	2,500
Astrocast [Member]
Investment Amount | $	$ 5,000
Investment Owned, Balance, Shares | shares	1,520
BlackSky [Member]
Investment Amount | $	$ 8,000
Investment Owned, Balance, Shares | shares	800
Lilium [Member]
Investment Amount | $	$ 41,000
Investment Owned, Balance, Shares | shares	4,100
Roivant Sciences [Member]
Investment Amount | $	$ 30,000
Investment Owned, Balance, Shares | shares	3,000
Sarcos Robotics [Member]
Investment Amount | $	$ 21,000
Investment Owned, Balance, Shares | shares	2,100
Autonomous aerial vehicle company [Member]
Investment Amount | $	$ 3,000	[2]
Investment Owned, Balance, Shares | shares	3,000	[2]
[1]	Investments are in publicly-traded marketable securities, unless otherwise noted.
[2]	Investment in privately-held company.

Investments and Fair Value Me_5

Investments and Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)oz
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revenues	$ 392,146	$ 289,366	$ 1,109,022	$ 770,582
Unrealized loss from marketable securities	7,200		7,238	$ 0
Alternative Investment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weight of commodities purchased | oz				100
Investment in Physical Commodities	50,900		50,900
Commercial Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revenues	19,000		$ 22,000
Maximum [Member] | Investment Agreement [Member] | Commercial Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Subscription contract term			10 years
Maximum contract value	640,200		$ 640,200
Contractual option amounts	$ 82,900		$ 82,900
Minimum [Member] | Investment Agreement [Member] | Commercial Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Subscription contract term			3 years

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Total property and equipment, gross	$ 120,992	$ 117,940
Less: accumulated depreciation and amortization	(92,214)	(88,399)
Total property and equipment, net	28,778	29,541
Leasehold improvements [Member]
Total property and equipment, gross	80,215	85,196
Computer equipment, software, and other [Member]
Total property and equipment, gross	25,451	22,275
Furniture and fixtures [Member]
Total property and equipment, gross	10,021	9,976
Construction in progress [Member]
Total property and equipment, gross	$ 5,305	$ 493

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Balance Sheet Related Disclosures [Abstract]
Accrued payroll and related expenses	$ 100,157	$ 85,466
Accrued other liabilities	79,310	73,080
Total accrued liabilities	$ 179,467	$ 158,546

Balance Sheet Components - Addi

Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Depreciation and amortisation expense excluding the impact of foreign exchange fluctuations	$ 3.1	$ 2.5	$ 9.3	$ 9.3

Equity Method Investments - Add

Equity Method Investments - Additional information (Detail) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Nov. 30, 2019	Sep. 30, 2021	Sep. 30, 2020
Schedule of Equity Method Investments [Line Items]
Payments made to acquire equity method investments		$ 3,000	$ 2,500
Palantir Technologies Japan, K.K. [Member]
Schedule of Equity Method Investments [Line Items]
Number of shares purchased	100,000
Payments made to acquire equity method investments	$ 25,000
Equity method investment ownership percentage	50.00%
SOMPO [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment ownership percentage	50.00%

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Millions	Apr. 01, 2021	Oct. 30, 2014	Sep. 30, 2021
2014 Revolving Credit Facility [Member]
Long-term Debt [Line Items]
Line of credit facility variable interest rate description			London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%
Line of credit facility commitment fee percentage		0.375%
Line of credit maturity date			Jun. 4, 2023
Debt instrument carrying amount			$ 0
Debt Instrument, periodic payment, principal	$ 200
2014 Revolving Credit Facility [Member] | Incremental Credit Facility [Member]
Long-term Debt [Line Items]
Undrawn revolving credit facility amount			400
Increase in borrowing capacity	200
2014 Revolving Credit Facility [Member] | Minimum [Member]
Long-term Debt [Line Items]
Line of credit minimum liquidity to be maintained			$ 50
2014 Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Long-term Debt [Line Items]
Line of credit facility variable interest rate spread			2.75%
Line of credit facility variable interest rate description		London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75%
Amended 2014 Revolving Credit Facility [Member]
Long-term Debt [Line Items]
Debt instrument maximum borrowing capacity	400
Amended 2014 Revolving Credit Facility [Member] | Term Loan [Member] | Incremental Credit Facility [Member]
Long-term Debt [Line Items]
Undrawn revolving credit facility amount	$ 100

Commitments and Contingencies

Commitments and Contingencies - Summary of Investment commitments (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)shares
Commitments and Contingencies [Line Items]
Number of shares committed to purchase | shares	22,650,000
Purchase Price Commitment | $	$ 226,500
Mobility Company [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 11, 2021	[1]
Number of shares committed to purchase | shares	2,000,000	[1]
Purchase Price Commitment | $	$ 20,000	[1]
Wejo [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	May 28, 2021
Number of shares committed to purchase | shares	3,500,000
Purchase Price Commitment | $	$ 35,000
Babylon Health [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 3, 2021	[1],[2]
Number of shares committed to purchase | shares	3,500,000	[1],[2]
Purchase Price Commitment | $	$ 35,000	[1],[2]
Boxed [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 13, 2021	[2]
Number of shares committed to purchase | shares	2,000,000	[2]
Purchase Price Commitment | $	$ 20,000	[2]
Pear Therapeutics [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 21, 2021
Number of shares committed to purchase | shares	1,000,000
Purchase Price Commitment | $	$ 10,000
Autonomous Vehicle Company [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jun. 22, 2021	[2]
Number of shares committed to purchase | shares	1,800,000	[2]
Purchase Price Commitment | $	$ 18,000	[2]
Fast Radius [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jul. 18, 2021	[2]
Number of shares committed to purchase | shares	2,000,000	[2]
Purchase Price Commitment | $	$ 20,000	[2]
Tritium [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jul. 27, 2021	[2]
Number of shares committed to purchase | shares	1,500,000	[2]
Purchase Price Commitment | $	$ 15,000	[2]
AdTheorent [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Jul. 27, 2021	[2]
Number of shares committed to purchase | shares	1,500,000	[2]
Purchase Price Commitment | $	$ 15,000	[2]
FinAccel [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Aug. 2, 2021
Number of shares committed to purchase | shares	1,000,000
Purchase Price Commitment | $	$ 10,000
Energy Vault [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Sep. 8, 2021	[2]
Number of shares committed to purchase | shares	850	[2]
Purchase Price Commitment | $	$ 8,500	[2]
Electric vehicle charging company [Member]
Commitments and Contingencies [Line Items]
Investment Agreement Date	Sep. 10, 2021	[2]
Number of shares committed to purchase | shares	2,000,000	[2]
Purchase Price Commitment | $	$ 20,000	[2]
[1]	The Company’s investment closed after September 30, 2021. See further discussion in Note 14. Subsequent Events.
[2]	Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) shares in Thousands, $ in Thousands	1 Months Ended		9 Months Ended
	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2021	Dec. 31, 2020
Loss Contingencies [Line Items]
Letter of credit outstanding amount			$ 88,100	$ 116,800
Purchase Price Commitment			$ 226,500
Number of shares committed to purchase			22,650
Investment Commitments [Member] | Investment Agreement [Member]
Loss Contingencies [Line Items]
Purchase Price Commitment			$ 226,500
Number of shares committed to purchase			22,700
Purchase Commitment One [Member]
Loss Contingencies [Line Items]
Minimum annual commitment		$ 1,490,000
Long-term Purchase Commitment, Description		If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.
Purchase Commitment For Contract Year One			$ 34,000
Purchase Commitment For Contract Year two			167,000
Purchase Commitment Two [Member]
Loss Contingencies [Line Items]
Minimum annual commitment	$ 45,000
Satisfied purchase commitment			$ 8,000

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares	Sep. 30, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Common stock, shares authorized	22,701,005,000	22,701,005,000
Common stock, shares issued	1,991,118,000	1,792,140,000
Common stock, shares outstanding	1,991,118,000	1,792,140,000
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	1,900,441,000	1,542,058,000
Common stock, shares outstanding	1,900,441,000	1,542,058,000
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized	2,700,000,000	2,700,000,000
Common stock, shares issued	89,672,000	249,077,000
Common stock, shares outstanding	89,672,000	249,077,000
Common Class F [Member]
Class of Stock [Line Items]
Common stock, shares authorized	1,005,000	1,005,000
Common stock, shares issued	1,005,000	1,005,000
Common stock, shares outstanding	1,005,000	1,005,000

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Sep. 30, 2021
Minimum ownership threshold		100,000,000
Dividends declared		$ 0
Common Class B [Member]
Number of shares exchanged	1,005,000
Common Class F [Member]
Voting power		50.00%
Redeemable Convertible Preferred Stock [Member] | Common Class B [Member]
Number of shares issued for conversion	4,017,378
Convertible preferred stock [Member] | Common Class B [Member]
Number of shares issued for conversion	793,725,807

Stock-Based Compensation - Add

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Common shares issuable upon full vesting of the growth units	1,500,000
Unrecognized share based compensation expense		$ 940,000,000
Unrecognized share based compensation expense, period for recognition		8 years
Stock-based compensation		$ 611,308	$ 1,028,914
Restricted Stock Units (RSUs) [Member]
Unrecognized share based compensation expense		$ 985,100
Unrecognized share based compensation expense, period for recognition		3 years
Outstanding RSUs unvested		166,033,000		184,870,000
Growth units [Member]
Stock-based compensation	$ 1,200
Outstanding RSUs unvested	3,600,000

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares
Share-based Payment Arrangement [Abstract]
Beginning Balance of Options Outstanding | shares	535,767,000
Options exercised | shares	(155,720,000)
Options canceled and forfeited | shares	(5,518,000)
Ending Balance of Options Outstanding | shares	374,529,000	535,767,000
Options vested and exercisable as of September 30, 2021 | shares	182,617,000
Beginning Balance of Weighted-Average Exercise Price Per Share | $ / shares	$ 6.12
Options exercised | $ / shares	3.05
Options canceled and forfeited | $ / shares	5.26
Ending Balance of Weighted-Average Exercise Price Per Share | $ / shares	7.40	$ 6.12
Options vested and exercisable as of September 30, 2021 | $ / shares	$ 4.48
Weighted- Average Remaining Contractual Life (years)	8 years 9 months 25 days	7 years 11 months 26 days
Options vested and exercisable as of September 30, 2021	7 years 29 days
Aggregate Intrinsic Value | $	$ 6,230,308	$ 9,340,245
Options vested and exercisable as of September 30, 2021 | $	$ 3,571,719

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU Activity (Detail) - Restricted Stock Units	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested and Outstanding Beginning Balance | shares	184,870,000
RSUs granted | shares	25,093,000
RSUs vested | shares	(37,123,000)
RSUs canceled | shares	(6,807,000)
Unvested and Outstanding Ending Balance | shares	166,033,000
Weighted Average Grant Date Fair Value per Share Beginning Balance | $ / shares	$ 6.97
RSUs granted | $ / shares	24.01
RSUs vested | $ / shares	8.17
RSUs canceled | $ / shares	8.18
Weighted Average Grant Date Fair Value per Share Ending Balance | $ / shares	$ 9.22

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	[1]	$ 184,835	$ 846,959	$ 611,308	$ 1,028,914
Cost of revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		14,860	94,385	54,866	120,285
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		57,124	263,958	186,418	322,353
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		34,472	256,769	122,976	309,698
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		$ 78,379	$ 231,847	$ 247,048	$ 276,578
[1]	On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2021USD ($)
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Accelerated Cost	$ 769.5
Growth units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Accelerated Cost	$ 8.4

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Provision (benefit) for income taxes	$ 1,438	$ (8,543)	$ (1,121)	$ (5,043)
Minimum [Member]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	19.00%
Maximum [Member]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	25.00%

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Numerator
Net loss attributable to common stockholders	$ (102,137)	$ (853,319)	$ (364,191)	$ (1,018,048)
Less: Change in fair value attributable to participating securities	0	0	0	(5,483)
Net loss attributable to common stockholders, for diluted net loss per share	$ (102,137)	$ (853,319)	$ (364,191)	$ (1,023,531)
Denominator
Weighted-average shares used in computing net loss per share, basic	1,964,395	905,462	1,893,911	713,879
Weighted-average shares used in computing net loss per share, diluted	1,964,395	905,462	1,893,911	716,027
Net loss per share
Net loss per share attributable to common stockholders, basic	$ (0.05)	$ (0.94)	$ (0.19)	$ (1.43)
Net loss per share attributable to common stockholders, diluted	$ (0.05)	$ (0.94)	$ (0.19)	$ (1.43)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares shares in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	553,630	810,283
Warrants to purchase redeemable convertible and convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		19,068
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	13,042
Options and Stock Appreciation Rights issued and outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	374,555	587,977
RSUs outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	166,033	199,655
Growth units outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		3,583

Segment and Geographic Inform_3

Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - Operating Segments [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Revenues	$ 392,146	$ 289,366	$ 1,109,022	$ 770,582
Contribution	223,883	163,458	646,546	395,094
Government [Member]
Segment Reporting Information [Line Items]
Revenues	217,836	162,561	658,375	420,257
Contribution	125,706	93,962	400,705	226,186
Commercial [Member]
Segment Reporting Information [Line Items]
Revenues	174,310	126,805	450,647	350,325
Contribution	$ 98,177	$ 69,496	$ 245,841	$ 168,908

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Loss from operations		$ (91,941)	$ (847,777)	$ (352,103)	$ (1,017,107)
Stock-based compensation expense	[1]	184,835	846,959	611,308	1,028,914
Reconciling items
Segment Reporting Information [Line Items]
Research and development expenses		59,844	57,146	180,335	156,832
General and administrative expenses		71,145	107,130	207,006	226,455
Stock-based compensation expense		184,835	846,959	611,308	1,028,914
Operating Segments
Segment Reporting Information [Line Items]
Contribution		$ 223,883	$ 163,458	$ 646,546	$ 395,094
[1]	On September 30, 2020, in connection with the Direct Listing, the Company incurred $769.5 million and $8.4 million of stock-based compensation using the accelerated attribution method related to the satisfaction of the performance-based vesting condition for RSUs and growth units, respectively, that had satisfied the service-based vesting condition as of such date.

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2021		Sep. 30, 2020		Sep. 30, 2021		Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Revenues	$ 392,146		$ 289,366		$ 1,109,022		$ 770,582
Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 392,146		$ 289,366		$ 1,109,022		$ 770,582
Concentration risk, percentage	100.00%		100.00%		100.00%		100.00%
United States [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 227,285		$ 156,336		$ 625,662		$ 391,106
Concentration risk, percentage	58.00%		54.00%		56.00%		51.00%
United Kingdom [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 47,914		$ 35,432		$ 122,234		$ 94,440
Concentration risk, percentage	12.00%		12.00%		11.00%		12.00%
France [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues					$ 61,558		$ 78,572
Concentration risk, percentage					6.00%		10.00%
Rest of world [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 116,947	[1]	$ 97,598	[1]	$ 299,568	[2]	$ 206,464	[2]
Concentration risk, percentage	30.00%	[1]	34.00%	[1]	27.00%	[2]	27.00%	[2]
[1]	No other country represents 10% or more of total revenue for the three months ended September 30, 2021 or 2020.
[2]	No other country represents 10% or more of total revenue for the nine months ended September 30, 2021 or 2020.

Segment and Geographic Inform_6

Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue Benchmark [Member] | Minimum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10.00%	10.00%	10.00%	10.00%

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($) $ in Thousands		Oct. 01, 2021	Sep. 30, 2021	Dec. 31, 2021
Subsequent Event [Line Items]
Number of shares committed to purchase			22,650,000
Additional purchase price commitment			$ 226,500
Investment Owned, Shares	[1]		19,020
Aggregate purchase price	[1]		$ 153,000
Investment Agreement [Member] | Forecast [Member]
Subsequent Event [Line Items]
Investment Owned, Shares				5,500,000
Aggregate purchase price				$ 55,000
Investment Agreement [Member] | Commercial Contract [Member] | Maximum [Member]
Subsequent Event [Line Items]
Subscription contract term			10 years
Investment Agreement [Member] | Commercial Contract [Member] | Minimum [Member]
Subsequent Event [Line Items]
Subscription contract term			3 years
Subsequent Event [Member] | Equity Investment [Member]
Subsequent Event [Line Items]
Number of shares committed to purchase		2,600,000
Additional purchase price commitment		$ 26,000
Subsequent Event [Member] | Investment Agreement [Member] | Commercial Contract [Member] | Maximum [Member]
Subsequent Event [Line Items]
Enterprise Subscription Contract Value		$ 26,000
Subsequent Event [Member] | Additional Investment Agreement [Member] | Maximum [Member]
Subsequent Event [Line Items]
Subscription contract term		4 years
Subsequent Event [Member] | Additional Investment Agreement [Member] | Minimum [Member]
Subsequent Event [Line Items]
Subscription contract term		3 years
[1]	Investments are in publicly-traded marketable securities, unless otherwise noted.

Subsequent Events - Summary of

Subsequent Events - Summary of Additional Investment Commitments (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2021USD ($)shares
Additional Investment Commitments [Line Items]
Committed share amount | shares	2,600,000
Committed investment amount | $	$ 26,000
Telecommunications company [Member]
Additional Investment Commitments [Line Items]
Investment Agreement Date	Oct. 6, 2021	[1]
Committed share amount | shares	1,600	[1]
Committed investment amount | $	$ 16,000	[1]
Rigetti & Co, Inc. [Member]
Additional Investment Commitments [Line Items]
Investment Agreement Date	Oct. 6, 2021	[1]
Committed share amount | shares	1,000	[1]
Committed investment amount | $	$ 10,000	[1]
[1]	Commercial contract contains termination for convenience clauses in the event the proposed business combination and/or the Company’s proposed investment is not completed.

Subsequent Event - Summary of I

Subsequent Event - Summary of Investment Commitments (Detail) - USD ($) $ in Thousands		Dec. 31, 2021	Sep. 30, 2021
Subsequent Event [Line Items]
Share Amount	[1]		19,020
Investment Amount	[1]		$ 153,000
Investment Agreement [Member] | Forecast [Member]
Subsequent Event [Line Items]
Share Amount		5,500,000
Investment Amount		$ 55,000
Babylon Health [Member] | Forecast [Member]
Subsequent Event [Line Items]
Share Amount	[2]	3,500,000
Investment Amount	[2]	$ 35,000
Mobility Company [Member] | Forecast [Member]
Subsequent Event [Line Items]
Share Amount	[2]	2,000,000
Investment Amount	[2]	$ 20,000
[1]	Investments are in publicly-traded marketable securities, unless otherwise noted.
[2]	Reflected as commitments in Note 8. Commitments and Contingencies - Investment Commitments as of September 30, 2021.